A major advocacy group for breast cancer patients is backing away from promoting the controversial drug, Avastin, for use in new patients. According to a report in The Wall Street Journal, the new stance by the Susan G. Komen Race for the Cure comes after the U.S. Food and Drug Administration (FDA) said it was beginning the process … [Read more...] about Recent Avastin Woes Prompt Breast Cancer Group to Change Its Position